Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: CEIm HM Hospitales ×

CEIm HM Hospitales

This institution is selected. Its supporting articles are shown below.

CEIm HM Hospitales1

Articles mentioning CEIm HM Hospitales

1 articles · page 1 of 1

1316 Initial monotherapy clinical activity of invikafusp alfa, a first-in-class TCR β-chain-targeted bifunctional antibody, in tissue-agnostic, TMB-H patients from STARt-001, a phase 1/2 trial

jitc · abstract · 2025-11-07 · 2 matching annotations

89.6%

Memorial Sloan Kettering Cancer Center CEIm HM Hospitales Dana Farber Cancer Institute colorectal cancer FDA Invikafusp alfa TMB-H solid tumors invikafusp STAR0602 TMB-H

…T # 2023-505334-10-01) Institutional Review Board/Privacy Board/Memorial Sloan Kettering Cancer Center (23-239) CEIm HM Hospitales (CT # 2023-505334-10-01) WCG IRB (I…

Browse institutions

CEIm HM Hospitales

Articles mentioning CEIm HM Hospitales

1316 Initial monotherapy clinical activity of invikafusp alfa, a first-in-class TCR β-chain-targeted bifunctional antibody, in tissue-agnostic, TMB-H patients from STARt-001, a phase 1/2 trial